Symrise shares plunge despite revenue growth on cautious outlook

Symrise, the fragrance and flavor manufacturer, saw its stock price drop by more than 10 percent following its third-quarter 2026 results. While the company reported organic revenue growth of 5.3 percent, reaching 1.31 billion euros and exceeding analyst expectations, investors reacted negatively to the company's guidance.

The company indicated that its adjusted EBITDA margin is now expected to fall within the lower half of its previously stated 21.5 to 22.5 percent target range. Management cited upcoming investments in IT, innovation, and personnel as factors that would weigh on profitability. Additionally, Symrise expects organic revenue growth for the full year to land near the middle of its 2 to 4 percent forecast range, with growth momentum expected to slow in the fourth quarter due to a higher year-on-year comparison base.

Despite the stock volatility, the company noted a recovery in segments such as pet nutrition and Care & Wellness. The Taste, Nutrition & Health division saw organic revenue increase by 5.2 percent, while Scent & Care grew by 5.6 percent.